Zobrazeno 1 - 10
of 115
pro vyhledávání: '"R James White"'
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0127443 (2015)
Altered levels of circulating extracellular miRNA in plasma and serum have shown promise as non-invasive biomarkers of disease. However, unlike the assessment of cellular miRNA levels for which there are accepted housekeeping genes, analogous referen
Externí odkaz:
https://doaj.org/article/add61903623044b88859e64dfbf3884b
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Right ventricular (RV) dysfunction in pulmonary arterial hypertension (PAH) is associated with poor outcomes. Cardiac magnetic resonance imaging (cMRI) is the gold standard for volumetric assessment, and few reports have correlated 6‐min w
Externí odkaz:
https://doaj.org/article/6c7fa66628d04414a0fc964f4d4891fb
Autor:
Daniel Lachant, Allison Light, Michael Lachant, Jeffrey Annis, Anna Hemnes, Evan Brittain, R. James White
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 3, Pp n/a-n/a (2023)
Abstract Pulmonary arterial hypertension (PAH) patients have low activity. Activity intensity or duration could be a measure of clinical status or improvement. We aimed to determine whether standard or novel actigraphy measures could detect increases
Externí odkaz:
https://doaj.org/article/9b0ecc7f58844ec1ac04a64f8bce187c
Autor:
Franck F. Rahaghi, Vijay P. Balasubramanian, Robert C. Bourge, Charles D. Burger, Murali M. Chakinala, Michael S. Eggert, Jean M. Elwing, Jeremy Feldman, Christopher King, James R. Klinger, Stephen C. Mathai, John Wesley McConnell, Harold I. Palevsky, Ricardo Restrepo‐Jaramillo, Zeenat Safdar, Jeffrey S. Sager, Namita Sood, Roxana Sulica, R. James White, Nicholas S. Hill
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Dual combination therapy with a phosphodiesterase‐5 inhibitor (PDE5i) and endothelin receptor antagonist is recommended for most patients with intermediate‐risk pulmonary arterial hypertension (PAH). The RESPITE and REPLACE studies sugge
Externí odkaz:
https://doaj.org/article/9f5b66c79cd442eda20ab75c66cf4ff1
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in morbid obesity after venous thromboembolism (VTE). In this observational study, patients were followed up after intermediate- or high-risk pulmonary embolism
Externí odkaz:
https://doaj.org/article/b65d71a060b640929c49d0c93e69d468
Autor:
R. James White, Keyur Parikh, Roblee Allen, Jeremy Feldman, Carlos Jerjez-Sanchez, Lei Pan, Anne Keogh, C. Dario Vizza, Shelley Shapiro, Kathryn Gordon, Meredith Broderick, Sonja Bartolome
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Oral treprostinil may be an option for low- and intermediate-risk patients with pulmonary arterial hypertension, a rare lung vascular disease. This open-label extension study collected data on participants who completed previously reported, placebo-c
Externí odkaz:
https://doaj.org/article/4634a7d4f5f645a1817a6db694d99d12
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Right ventricular (RV) function is a predictor of outcomes in pulmonary arterial hypertension (PAH). The 6-min walk test (6MWT) is likely an indirect measure of RV function during exercise, but changes in absolute walk distance can also be influenced
Externí odkaz:
https://doaj.org/article/bf3e554394b44ce59de2cf928801fd48
Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension
Autor:
Daniel Lachant, Ethan Kennedy, Blaise Derenze, Allison Light, Michael Lachant, R. James White
Publikováno v:
Chest. 162:1340-1348
The SARS-CoV-2 pandemic has limited objective physiologic assessments. A standardized remote alternative is not currently available. "Cardiac effort" (CE), that is, the total number of heart beats divided by the 6-min walk test (6MWT) distance (beats
Autor:
Daniel Lachant, Christina Bach, Bennett Wilson, Vaseem Chengazi, Bruce Goldman, Neil Lachant, Anthony Pietropaoli, Scott Cameron, R. James White
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Long-term outcomes after acute pulmonary embolism vary from complete resolution to chronic thromboembolic pulmonary hypertension (CTEPH). Guidelines after acute pulmonary embolism are generally limited to anticoagulation duration. We assessed patient
Externí odkaz:
https://doaj.org/article/f749494d24e448c1a5c4b3a28b3be990
Autor:
R. JAMES WHITE, JOANNA PEPKE-ZABA, VIJAY P BALASUBRAMANIAN, JEAN M. ELWING, MADELON MC VONK, STEPHAN H. ROSENKRANZ, LINDA M CADARET, SANDEEP SAHAY, ZAIXIN YU, LOUIS HOLDSTOCK, C.Q. DENG, SCOTT SEAMAN, MEREDITH BRODERICK, CARMINE DV VIZZA
Publikováno v:
Chest. 162:A2301-A2303